Patient-based drug discovery's latest news

We will participate at this year’s Keystone Symposium on Modern Phenotypic Drug Discovery: From Chemical Biology to Therapy that will take place from May 22nd – May 25th 2022 in...

Ksilink proudly takes part of the EC funded EnvironMENTAL consortium. Want to know more? You are invited to join a series of seminars! EnvironMENTAL aims at identifying the...

Ksilink proudly announces the publication of exciting results in the journal “Cancer Biology & Therapy”. In fact, the technology for Personalized Functional Profiling (PFP) of...

A l'occasion de la journée de l'amitié franco-allemande, Ksilink vous présente ses meilleurs vœux pour l'année 2022 ! Version française Anlässlich des Tages der...

What you see here is neither a virtual firework nor has Ksilink become an expressionist. We took this beautiful picture, figuring the AI-based analysis of the pharmacological...

Ksilink is happy to announce the initiation of the ANR funded project "Target-agnostic drug discovery approaches for neuromuscular diseases (TREAD)". This project is supporting...

Ksilink is happy to have welcomed the team of Prof. Valérie Mezger-Lallemand from Université Didérot to initiate a collaboration with the aim to establish a new patient-based disease model to identify …

We are proud to be present with two posters during the AI powered Drug Discovery Symposium from 8-9th of November 2021 in London, at Francis Crick Institute. Download our poster...

We are happy to welcome you on our new website. We will keep you informed about news and activities around patient-based drug discovery. Come and visit us on www.ksilink.com !!